925672-85-1

Usage

Uses

Used in Pharmaceutical Industry:
1,6-DIBROMO-3-ISOQUINOLINAMINE is used as an intermediate in the synthesis of pharmaceuticals for its ability to be incorporated into the molecular structures of various medicinal compounds. Its reactivity and structural features make it a valuable component in the development of new drugs.
Used in Organic Synthesis:
In the field of organic synthesis, 1,6-DIBROMO-3-ISOQUINOLINAMINE is utilized as a reagent in chemical reactions, particularly for the production of heterocyclic compounds. Its bromo substitution allows for a range of reactions that can lead to the formation of complex organic molecules.
Used in Chemical Research:
1,6-DIBROMO-3-ISOQUINOLINAMINE also serves a purpose in chemical research, where it can be employed to study the properties and reactions of heterocyclic compounds. Its unique structure provides opportunities for exploration in academic and industrial research settings.
Safety Precautions:
Given its potential hazards, 1,6-DIBROMO-3-ISOQUINOLINAMINE must be handled and stored with appropriate safety measures. It is important to avoid ingestion, inhalation, or skin absorption due to its harmful nature. Proper protective equipment and handling procedures should be followed to minimize risks during its use in various applications.

InChI:InChI=1/C9H6Br2N2/c10-6-1-2-7-5(3-6)4-8(12)13-9(7)11/h1-4H,(H2,12,13)

Upstream product

• 925672-88-4 4-bromo-2-(cyanomethyl)benzonitrile 
• 925672-87-3 C₁₁H₇BrN₂O₂ 
• 105942-08-3 4-bromo-6-fluorobenzonitrile 

Downstream Products

• 925672-98-6 C₁₇H₁₅BrN₂O 
• 925673-01-4 C₁₉H₁₇BrN₂O₂ 
• 891785-28-7 6-bromo-isoquinolin-3-ylamine 

Relevant academic research and scientific papers

FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE

The invention relates to thiazole compounds of Formula (I) and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein. The invention also relates to the therapeutic use of such thiazole compounds and compositions thereof in treating disease states associated with abnormal cell growth, cancer, inflammation, and metabolic disorders.

THIADIAZOLE MODULATORS OF PKB

The invention relates to thiazole compounds of Formula I and Formula II and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein. The invention also relates to the th

HETEROCYCLIC MODULATORS OF PKB

The invention relates to heterocyclic compounds of Formula I and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein Formula (I). The invention also relates to the therapeutic use of such compounds and compositions thereof in treating disease states associated with abnormal cell growth, cancer, inflammation, and metabolic disorders.

An efficient synthesis of 1,6- and 1,7-dibromo-3-aminoisoquinolines: versatile templates for the preparation of functionalized isoquinolines

An efficient synthetic route to 1,6- and 1,7-dibromo-3-aminoisoquinoline was devised. These intermediates served as ideal templates for the preparation of 3-aminoisoquinoline analogues functionalized at C(6) or C(7).